Pre-Peel Care, Recovery Instructions, and Complication Referral

Prepare through assessment rather than a standard recipe

Pre-peel care begins with suitability, not a mandatory month of several active ingredients. Review the cosmetic goal, current barrier, medicines, recent procedures, infection history, previous reactions, pigment changes, and scar history. Identify the complete formulation and its directions. A product permitted by Virginia can still be unsuitable for the client or region.

Some medical or commercial protocols include preconditioning. Follow the appropriate prescriber or product instructions rather than inventing one program for every person. Adding retinoids and acids can itself create irritation. A client reporting stinging or active dermatitis should not receive more priming actives to prove they are ready.

Prescription boundaries and timing

Hydroquinone-containing lightening products are not approved for OTC sale in the United States. Prescription hydroquinone, prescription-strength azelaic acid, retinoids, antivirals, and other medicines require authorized medical decisions. Do not recommend a standard prescription concentration from phototype alone or describe unapproved OTC hydroquinone as routine mandatory prep.

Recent procedures and medicines have different restrictions. Current isotretinoin warnings cover waxing and skin-resurfacing procedures during use and for at least six months afterward. Other treatment intervals depend on the product, procedure, condition, and responsible provider. Do not tell clients to stop medicines or supplements independently to fit a universal discontinuation table.

A history of herpes can require medical planning for some procedures. The prescriber decides whether prophylaxis is indicated and chooses drug, dose, and timing. The esthetician records the relevant history and instructions, and defers active or suspected infection. A preset valacyclovir schedule is not part of independent cosmetic prescribing authority.

Coordinate with prior medical care

Ask about injections, surgery, laser, needling, and other recent treatment, including the actual date, region, provider, and instructions. Surface appearance can improve before deeper recovery is complete. Do not assume a fixed number of days makes every peel compatible, or claim that any exfoliation physically moves every filler.

If a clearance note is vague, obtain the needed specific information through the appropriate process. Medical advice does not override a product contraindication or expand the operator's scope. New symptoms since clearance require reassessment. The client's request to proceed quickly does not remove those conditions.

Recovery and home care

Do not promise that every peel sheds on day three and is healed on day seven. Product, exposure, skin condition, and complications affect recovery. Lack of visible peeling does not prove no effect, and visible peeling does not prove success. Document expected responses under the actual protocol without turning them into a guarantee.

Occlusive or barrier-oriented products can support suitable care, but should not be layered over an unresolved chemical exposure or infected-looking wound to avoid assessment. A moisturizer is not a treatment for every complication. Medical wound instructions take precedence when a medical injury is involved.

Recognize concerning changes

Worsening pain, spreading redness, marked swelling, blistering, drainage, fever, wound opening, unusual pigment loss, or ocular symptoms warrant appropriate reassessment or referral. An arbitrary forty-eight-hour redness threshold cannot diagnose all complications. Some expected responses last longer; some serious problems appear earlier. Severity, progression, and context matter.

Possible infection or herpes reactivation requires medical evaluation, not a cosmetic diagnosis followed by an over-the-counter substitute. Do not independently prescribe antibiotics, topical steroids, or antivirals. Avoid applying another peel to correct an unexpected pigment change before its cause and recovery are assessed.

Follow-up example

A client reports increasing pain and grouped blisters after a peel. Record the symptoms and timing, advise prompt medical evaluation, and provide the product and exposure information needed by the clinician. Do not label it definitely normal shedding or diagnose herpes yourself. Stop further cosmetic injury-producing services while the condition is unresolved.

Another client has mild dryness under the expected protocol but admits using a home scrub immediately afterward. Review compatible aftercare and actual symptoms, document the additional exposure, and reassess before future treatment. If symptoms persist or worsen, recommend appropriate care rather than offering a stronger in-office correction.

Record and improve the plan

The record should include preparation, medical coordination, product, application and ending details, response, instructions, follow-up contact, and referrals. Document the actual event, including early stopping or deviations. Preserve accurate information for product or device reporting if needed.

For examination questions, separate preconditioning, prescription authority, recovery support, and emergency care. A safe plan is individualized and current. Fixed drug doses, universal washouts, and promised recovery dates can appear precise while being wrong; the correct action uses verified instructions and the client's actual condition.

Sources and current rules

FDA hydroquinone status; AAD isotretinoin precautions; FDA peel warning. Checked October 7, 2026.